Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / France

Research and Innovation Action · Running

Decide-TB Validation of treatment decision algorithms for childhood tuberculosis at low levels of healthcare in high burden countries - effectiveness, implementation, and integration into policy and practices

Coordinator
Universite De Bordeaux, France
Runs
1 April 2023 to 31 March 2027
Status
Running
EU funding
€5.3m
Total cost
€5.3m
Partners
13 organisations in 6 countries
Type
Research and Innovation Action
Grant agreement
101103283

What the project is doing

In the project's own words, from its summary on CORDIS.

Childhood tuberculosis (TB) remains globally underdiagnosed and untreated. In 2022, WHO conditionally recommended the use of treatment decision algorithms (TDAs) to improve the diagnosis of pulmonary TB in children <10 years and called for the external validation of two suggested TDAs for children. The Decide-TB project aims to generate evidence for the implementation of a comprehensive TDA-based approach for TB in children living in high-burden, resource-limited countries, at district hospital and primary health centre levels, and to facilitate the integration of this evidence into practice and policy.

As an interdisciplinary consortium of researchers and national TB programs (NTPs), we will conduct a programmatic pilot of WHO-suggested TDAs, also integrating specific TDAs for children living with HIV and/or those malnourished, and severity assessment for shorter treatment decision in non-severe TB disease. Clinical mentoring tools and a Clinical Decision Support System will be developed. District information systems will be strengthened to collect individual data for program monitoring and supervision by NTPs, and for research.

The TDA-based approach will be tested in a pragmatic stepped wedge cluster-randomized trial, including effectiveness, implementation, socio-behavioural, economics and policy research components. The diagnostic accuracy of TDAs will be assessed in a parallel meta-analysis of children with presumptive TB from recent studies led by consortium members. The pragmatic trial and meta-analysis will contribute to external validation of the WHO-suggested TDAs.

Engagement of key stakeholders and decision-makers throughout the project will support adoption into international and national policies and into clinical practice. Through validation of TDAs, widespread policy adoption, and translation into clinical practice, Decide-TB will increase access to safe and effective TB management for children, thus reduce TB mortality and contribute to SDG3.

Topics

Who is involved

OrganisationCityCountryRole
Universite De BordeauxBordeauxFranceCoordinator
Klinikum Der Ludwig-Maximilians-Universitat MunchenMunchenGermanyThird party
Ludwig-Maximilians-Universitaet MuenchenPlaneggGermanyParticipant
Adera SASPessacFranceThird party
Institut De Recherche Pour Le DeveloppementMarseilleFranceParticipant
Instituto Nacional de SaúdeMarracueneMZParticipant
Ministerio Da SaudeMaputoMZParticipant
Universidade Eduardo MondlaneMaputoMZParticipant
Imperial College of Science Technology and MedicineLondonUnited KingdomParticipant
The University of SheffieldSheffieldUnited KingdomParticipant
Stellenbosch UniversityStellenboschSouth AfricaParticipant
Ministry of HealthLusakaZMParticipant
University of ZambiaLusakaZMParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI